Prophylactic colchicine therapy has been shown to be a safe and effective method of
eliminating the attacks and preventing the development of amyloidosis in patients with …

As determined in this study of 45 patients, the prolonged use of colchicine therapy in familial
Mediterranean fever (FMF) is safe and effective in preventing flares of FMF and amyloidosis …

This study sought to determine the appropriate starting dose of colchicine in children aged 2
to 4 years with familial Mediterranean fever (FMF) based on steady-state pharmacokinetics …

Aim Colchicine prophylaxis is the single most important factor in ameliorating familial
Mediterranean fever (FMF) for the prevention of both attacks and secondary amyloidosis …

The daily application of colchicine is the standard therapy for prophylaxis of attacks and
amyloid deposition in familial Mediterranean fever. However, because of many issues (eg …

Objective To define the characteristics of children expressing the FMF phenotype under
colchicine until it was ceased and to compare the clinical features of patients requiring …

This study aimed to investigate the effects of colchicine on growth parameters in familial
Mediterranean fever (FMF) patients. Fifty-one (29 girls, 22 boys) FMF patients were enrolled …

Aim Colchicine is the primary treatment for familial Mediterranean fever (FMF). Several
colchicine preparations are currently using available globally. This study aimed to describe …

Three hundred fifty children (younger than age 16) who had familial Mediterranean fever
(FMF) were given continuous prophylactic treatment with colchicine (1–2 mg/day) for 6–13 …

This study was performed to investigate the attack-free complaints of patients with familial
Mediterranean fever (FMF) and the impact of colchicine on these symptoms and on …